Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein

Journal of Virology

Volumn 79, Issue 3, 2005, Pages 1613-1622

  Gripon, Philippe ^a   Cannie, Isabelle ^a   Urban, Stephan ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MYRISTIC ACID; PEPTIDE DERIVATIVE; PRE S1 DOMAIN PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS L PROTEIN; EPITOPE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; PEPTIDE; PRESURFACE PROTEIN 1, HEPATITIS B SURFACE ANTIGEN; PROTEIN PRECURSOR; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG MECHANISM; DRUG POTENCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INCUBATION TIME; LIVER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; VIRUS ENVELOPE; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; SERODIAGNOSIS; SYNTHESIS; VIROLOGY;

AMINO ACID SEQUENCE; CELL LINE; CELLS, CULTURED; EPITOPES; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; MYRISTIC ACID; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN PRECURSORS; RECEPTORS, VIRUS;

EID: 13744257618     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.3.1613-1622.2005     Document Type: Article

References (32)

1. Acs, G., M. A. Sells, R. H. Purcell, P. Price, R. Engle, M. Shapiro, and H. Popper. 1987. Hepatitis B virus produced by transfected HepG2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. USA 84:4641-4644.
2. Berting, A., C. Fischer, S. Schaefer, W. Garten, H. D. Klenk, and W. H. Gerlich. 2000. Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus. Virus Res. 68: 35-49.
3. Bruss, V., and D. Ganem. 1991. The role of envelope proteins in hepatitis B virus assembly. Proc. Natl. Acad. Sci. USA 88:1059-1063.
4. Bruss, V., J. Hagelstein, E. Gerhardt, and P. R. Galle. 1996. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218:396-399.
5. Chang, C. M., K. S. Jeng, C. P. Hu, S. J. Lo, T. S. Su, L. P. Ting, C. K. Chou, S. H. Han, E. Pfaff, J. Salfeld, et al. 1987. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J. 6:675-680.
6. Chouteau, P., J. Le Seyec, I. Cannie, M. Nassal, C. Guguen-Guillouzo, and P. Gripon. 2001. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J. Virol. 75:11565-11572.
7. Ganem, D., and R. J. Schneider. 2001. Hepadnaviridae: the viruses and their replication, p. 2923-2969. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
8. Glebe, D., M. Aliakbari, P. Krass, E. V. Knoop, K. P. Valerius, and W. H. Gerlich. 2003. Pre-S1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J. Virol. 77:9511-9521.
9. Gripon, P., C. Diot, N. Theze, I. Fourel, O. Loreal, C. Brechot, and C. Guguen-Guillouzo. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 62:4136-4143.
10. Gripon, P., J. Le Seyec, S. Rumin, and C. Guguen-Guillouzo. 1995. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213:292-299.
11. Gripon, P., S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99:15655-15660.
12. Guguen-Guillouzo, C., and A. Guillouzo. 1986. Methods for preparation of adult and fetal hepatocytes, p. 1-12. In A. Guillouzo and C. Guguen-Guillouzo (ed.), Isolated and cultured hepatocytes. Les Éditions INSERM Paris, John Libbey and Co., Ltd., London, United Kingdom.
13. Gumina, G., G. Y. Song, and C. K. Chu. 2001. Advances in antiviral agents for hepatitis B virus. Antivir. Chem. Chemother. 12(Suppl. 1):93-117.
14. He, Y., R. Vassell, M. Zaitseva, N. Nguyen, Z. Yang, Y. Weng, and C. D. Weiss. 2003. Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites. J. Virol. 77:1666-1671.
15. Heermann, K. H., F. Kruse, M. Seifer, and W. H. Gerlich. 1987. Immunogenicity of the gene S and pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28:14-25.
16. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon. 1998. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 72:5573-5578.
17. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon. 1999. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 73:2052-2057.
18. Maeng, C. Y., C. J. Ryu, P. Gripon, C. Guguen-Guillouzo, and H. J. Hong. 2000. Fine mapping of virus-neutralizing epitopes on hepatitis B virus preS1. Virology 270:9-16.
19. Mason, W. S., G. Seal, and J. Summers. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36:829-836.
20. 2+/calmodulin. EMBO J. 23:712-718.
21. Neurath, A. R., S. B. Kent, N. Strick, and K. Parker. 1986. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429-436.
22. Neurath, A. R., B. Seto, and N. Strick. 1989. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7:234-236.
23. Persing, D. H., H. E. Varmus, and D. Ganem. 1987. The pre-S1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J. Virol. 61:1672-1677.
24. Pizarro, J. C., B. Vulliez-le Normand, M. M. Riottot, A. Budkowska, and G. A. Bentley. 2001. Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus. FEBS Lett. 509:463-468.
25. Russell, C. J., T. S. Jardetzky, and R. A. Lamb. 2001. Membrane fusion machines of paramyxoviruses: Capture of intermediates of fusion. EMBO J. 20:4024-4034.
26. Ryu, C. J., P. Gripon, H. R. Park, S. S. Park, Y. K. Kim, C. Guguen-Guillouzo, O. J. Yoo, and H. J. Hong. 1997. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen. J. Med. Virol. 52:226-233.
27. Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51-68.
28. Shouval, D., Y. Ilan, R. Adler, R. Deepen, A. Panet, Z. Even-Chen, M. Gorecki, and W. H. Gerlich. 1994. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. Vaccine 12:1453-1459.
29. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
30. Summers, J., J. M. Smolec, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75:4533-4537.
31. Urban, S., C. Schwarz, U. C. Marx, H. Zentgraf, H. Schaller, and G. Multhaup. 2000. Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction. EMBO J. 19:1217-1227.
32. Urban, S., and P. Gripon. 2002. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J. Virol. 76:1986-1990.